Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry.
Masanori YamamotoFumiaki YashimaShinichi ShiraiNorio TadaToru NaganumaMasahiro YamawakiFutoshi YamanakaKazuki MizutaniMasahiko NoguchiHiroshi UenoKensuke TakagiYohei OhnoMasaki IzumoHidetaka NishinaHiroto SuzuyamaKazumasa YamasakiKenji NishiokaDaisuke HachinoheYasushi FukuToshiaki OtsukaMasahiko AsamiYusuke WatanabeKentaro HayashidaOn Behalf Of The Ocean-Tavi InvestigatorsPublished in: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2024)
The S3UR has equivalent procedural complications to the S3 but with lower rates of PVL and significantly better valve performance. The better valve performance of the S3UR, particularly in smaller valve sizes, overcomes the remaining issue of balloon-expandable valves after TAVR.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- mitral valve
- ejection fraction
- left ventricular
- heart failure
- high resolution
- atrial fibrillation
- risk factors
- coronary artery disease
- metabolic syndrome
- skeletal muscle
- mass spectrometry